Regulation of TNF Receptor-Mediated Apoptosis
TNF 受体介导的细胞凋亡的调节
基本信息
- 批准号:7624483
- 负责人:
- 金额:$ 42.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-06-01 至 2008-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAnti-Inflammatory AgentsApoptosisApoptoticBindingBiologyCaspaseCell DeathCell SurvivalCellsCessation of lifeDevelopmentDiseaseFundingGenesGeneticGenetic TranscriptionHumanInflammatoryKnock-in MouseLeadLifeLinkLysineMediatingModelingModificationMolecularMusMutationNF-kappa BPathway interactionsPlayProtein BiosynthesisRegulationRoleSignal PathwaySignal TransductionSignaling MoleculeSiteT-LymphocyteTNF receptor-associated factor 2TRAF2 geneTestingTherapeuticTumor Necrosis Factor ReceptorTumor Necrosis Factor-alphaUbiquitinUbiquitinationcell typecytotoxichuman TNFRSF1A proteinimmune functionin vivoinsightloss of functionnovelreceptorresponsetranscription factortumor necrosis factor alpha receptorubiquitin-protein ligase
项目摘要
TNF binding to its receptor TNFR1 triggers cell survival or cell death but the
mechanisms that determine which of these two divergent responses is triggered remain to
be fully elucidated. One cell death checkpoint is the activation of NF-kappaB
transcription factors and subsequent induction of anti-apoptotic genes to inhibit the
apoptosis pathway. Preliminary studies performed demonstrated the existence of another
cell death checkpoint regulated by lysine 63-linked ubiquitination of RIP1.
Ubiquitination of lysine 377 on RIP1 inhibits TNF-induced apoptosis first through an
NF-kappaB-independent mechanism, and subsequently through an NF-kappaBdependent
mechanism. In contrast, in the absence of ubiquitination, RIP1 serves as a proapoptotic
signaling molecule. Thus, RIP1 is a dual-function molecule that can be either
pro-survival or pro-death depending on its ubiquitination state and thus serves as an NFkappaB-
independent cell death switch early in TNF signaling. This study proposes to
examine how this cell death checkpoint may be regulated. (1) The mechanism by which
ubiquitination of RIP1, or the lack of it, regulates the activation of caspases will be
examined. (2) The contribution by RIP1-binding partners to this checkpoint will also be
tested. (3) Animal models with genetic modifications in this novel cell death checkpoint
will be developed to study the relevance of this checkpoint in immune function. Insights
gained from these studies may lead to the development of pharmacological agents that
can modulate this cell death checkpoint. Such agents may have therapeutic potential in
inflammatory diseases where TNF plays a role.
TNF与其受体TNFR 1结合触发细胞存活或细胞死亡,但TNF受体的表达与细胞存活或细胞死亡无关。
决定这两种不同反应中哪一种被触发的机制仍然存在,
要充分阐明。一个细胞死亡检查点是NF-κ B的激活
转录因子和随后诱导抗凋亡基因以抑制细胞凋亡。
凋亡途径初步研究表明,存在另一种
细胞死亡检查点由RIP 1的赖氨酸63连接的泛素化调节。
RIP 1上赖氨酸377的泛素化首先通过抑制肿瘤坏死因子诱导的细胞凋亡,
NF-κ B非依赖性机制,随后通过NF-κ B依赖性
机制相反,在没有泛素化的情况下,RIP 1作为促凋亡蛋白发挥作用。
信号分子因此,RIP 1是一种双功能分子,可以是
促生存或促死亡,这取决于其泛素化状态,因此作为NF κ B-
TNF信号传导早期独立细胞死亡开关。本研究建议,
研究细胞死亡检查点是如何被调节的。(1)的机制
RIP 1的泛素化,或缺乏它,调节半胱天冬酶的激活,
考察(2)RIP 1绑定合作伙伴对此检查点的贡献也将是
测试. (3)在这种新的细胞死亡检查点中进行遗传修饰的动物模型
将被开发来研究这个检查点在免疫功能中的相关性。见解
从这些研究中获得的信息可能导致开发药理学试剂,
可以调节这个细胞死亡检查点。这些药物可能具有治疗潜力,
炎症性疾病,其中TNF发挥作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ADRIAN T TING其他文献
ADRIAN T TING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ADRIAN T TING', 18)}}的其他基金
Sensitization to RIPK1-dependent death as a strategy to enhance response of renal cell carcinoma (RCC) to immunotherapy
对 RIPK1 依赖性死亡的敏感性作为增强肾细胞癌 (RCC) 对免疫治疗反应的策略
- 批准号:
10721156 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Regulation of TNF Receptor-Mediated Apoptosis
TNF 受体介导的细胞凋亡的调节
- 批准号:
7896931 - 财政年份:2009
- 资助金额:
$ 42.38万 - 项目类别:
Cloning Negative Regulators of TNF Signaling
克隆 TNF 信号传导负调节因子
- 批准号:
6717458 - 财政年份:2004
- 资助金额:
$ 42.38万 - 项目类别:
Cloning Negative Regulators of TNF Signaling
克隆 TNF 信号传导负调节因子
- 批准号:
6873629 - 财政年份:2004
- 资助金额:
$ 42.38万 - 项目类别:
Regulation of TNF Receptor-mediated Cell Death
TNF 受体介导的细胞死亡的调节
- 批准号:
9888297 - 财政年份:2002
- 资助金额:
$ 42.38万 - 项目类别:
Regulation of TNF Receptor-Mediated Apoptosis
TNF 受体介导的细胞凋亡的调节
- 批准号:
7741227 - 财政年份:2002
- 资助金额:
$ 42.38万 - 项目类别:
Regulation of TNF Receptor-Mediated Apoptosis
TNF 受体介导的细胞凋亡的调节
- 批准号:
7995219 - 财政年份:2002
- 资助金额:
$ 42.38万 - 项目类别:
Regulation of TNF Receptor-Mediated Apoptosis
TNF 受体介导的细胞凋亡的调节
- 批准号:
6535729 - 财政年份:2002
- 资助金额:
$ 42.38万 - 项目类别:
Regulation of TNF Receptor-Mediated Apoptosis
TNF 受体介导的细胞凋亡的调节
- 批准号:
7903056 - 财政年份:2002
- 资助金额:
$ 42.38万 - 项目类别:
Regulation of TNF Receptor-Mediated Apoptosis
TNF 受体介导的细胞凋亡的调节
- 批准号:
8197670 - 财政年份:2002
- 资助金额:
$ 42.38万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists